EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation (Q40243206)
Jump to navigation
Jump to search
scientific article published on 15 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation |
scientific article published on 15 August 2006 |
Statements
1 reference
EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation (English)
1 reference
Hagop M Kantarjian
1 reference
Srdan Verstovsek
1 reference
Ayalew Tefferi
1 reference
Jorge E Cortes
1 reference
Taghi Manshouri
1 reference
Francis J Giles
1 reference
Jingxuan Pan
1 reference
Alfonso Quintás-Cardama
1 reference
Cem Akin
1 reference
Peter Lamb
1 reference
15 August 2006
1 reference
1 reference
109
1 reference
1
1 reference
315-322
1 reference
Identifiers
1 reference
1 reference